|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Edwards BK, Ward E, Kohler BA, et al:
Annual report to the nation on the status of cancer, 1975–2006,
featuring colorectal cancer trends and impact of interventions
(risk factors, screening, and treatment) to reduce future rates.
Cancer. 116:544–573. 2010.
|
|
5
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qu J, Zhao L, Zhang P, et al: MicroRNA-195
chemosensitizes colon cancer cells to the chemotherapeutic drug
doxorubicin by targeting the first binding site of BCL2L2 mRNA. J
Cell Physiol. View Article : Google Scholar : 2013.[Epub ahead of
print].
|
|
8
|
Catania A, Maira F, Skarmoutsou E, D’Amico
F, Abounader R and Mazzarino MC: Insight into the role of microRNAs
in brain tumors (Review). Int J Oncol. 40:605–624. 2012.PubMed/NCBI
|
|
9
|
Cherni I and Weiss GJ: miRNAs in lung
cancer: large roles for small players. Future Oncol. 7:1045–1055.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Le Pennec S and Savagner F: MiRNAs in
follicular thyroid tumors. Presse Med. 40:683–689. 2011.(In
French).
|
|
11
|
Agostini M, Pucciarelli S, Calore F, Bedin
C, Enzo M and Nitti D: miRNAs in colon and rectal cancer: a
consensus for their true clinical value. Clin Chim Acta.
411:1181–1186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Zhang Z, Sun L, et al:
microRNA-499-5p promotes cellular invasion and tumor metastasis in
colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis.
32:1798–1805. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Corte H, Manceau G, Blons H and
Laurent-Puig P: MicroRNA and colorectal cancer. Dig Liver Dis.
44:195–200. 2012. View Article : Google Scholar
|
|
17
|
Schetter AJ, Leung SY, Sohn JJ, et al:
MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boni V, Zarate R, Villa JC, et al: Role of
primary miRNA polymorphic variants in metastatic colon cancer
patients treated with 5-fluorouracil and irinotecan.
Pharmacogenomics J. 11:429–436. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Landi D, Gemignani F, Naccarati A, et al:
Polymorphisms within micro-RNA-binding sites and risk of sporadic
colorectal cancer. Carcinogenesis. 29:579–584. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Laios A, O’Toole S, Flavin R, et al:
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Mol Cancer. 7:352008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gottardo F, Liu CG, Ferracin M, et al:
Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mathé EA, Nguyen GH, Bowman ED, et al:
MicroRNA expression in squamous cell carcinoma and adenocarcinoma
of the esophagus: associations with survival. Clin Cancer Res.
15:6192–6200. 2009.PubMed/NCBI
|
|
23
|
Li X, Zhang Y, Zhang H, et al: miRNA-223
promotes gastric cancer invasion and metastasis by targeting tumor
suppressor EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang W, Tong JH, Chan AW, et al: Stathmin1
plays oncogenic role and is a target of microRNA-223 in gastric
cancer. PLoS One. 7:e339192012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mi S, Lu J, Sun M, et al: MicroRNA
expression signatures accurately discriminate acute lymphoblastic
leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA.
104:19971–19976. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miko E, Czimmerer Z, Csánky E, et al:
Differentially expressed microRNAs in small cell lung cancer. Exp
Lung Res. 35:646–664. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karakatsanis A, Papaconstantinou I,
Gazouli M, Lyberopoulou A, Polymeneas G and Voros D: Expression of
microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c,
miR-221, miR-222, and miR-223 in patients with hepatocellular
carcinoma or intrahepatic cholangiocarcinoma and its prognostic
significance. Mol Carcinog. 52:297–303. 2013. View Article : Google Scholar
|
|
28
|
Wong QW, Lung RW, Law PT, et al:
MicroRNA-223 is commonly repressed in hepatocellular
carcinoma and potentiates expression of Stathmin1.
Gastroenterology. 135:257–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sempere LF, Christensen M, Silahtaroglu A,
et al: Altered MicroRNA expression confined to specific epithelial
cell subpopulations in breast cancer. Cancer Res. 67:11612–11620.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xing J, Wan S, Zhou F, et al: Genetic
polymorphisms in pre-microRNA genes as prognostic markers of
colorectal cancer. Cancer Epidemiol Biomarkers Prev. 21:217–227.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lieberman DA: Clinical practice. Screening
for colorectal cancer. N Engl J Med. 361:1179–1187. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Motoyama K, Inoue H, Takatsuno Y, et al:
Over- and under-expressed microRNAs in human colorectal cancer. Int
J Oncol. 34:1069–1075. 2009.PubMed/NCBI
|
|
34
|
Zhang J, Xiao Z, Lai D, et al: miR-21,
miR-17 and miR-19a induced by phosphatase of regenerating liver-3
promote the proliferation and metastasis of colon cancer. Br J
Cancer. 107:352–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Monzo M, Navarro A, Bandres E, et al:
Overlapping expression of microRNAs in human embryonic colon and
colorectal cancer. Cell Res. 18:823–833. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu H, Zhu L, Liu B, et al: Genome-wide
microRNA profiles identify miR-378 as a serum biomarker for early
detection of gastric cancer. Cancer Lett. 316:196–203. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Slaby O, Svoboda M, Fabian P, et al:
Altered expression of miR-21, miR-31, miR-143 and miR-145 is
related to clinicopathologic features of colorectal cancer.
Oncology. 72:397–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ng EK, Tsang WP, Ng SS, et al:
MicroRNA-143 targets DNA methyltransferases 3A in colorectal
cancer. Br J Cancer. 101:699–706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen X, Guo X, Zhang H, et al: Role of
miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene.
28:1385–1392. 2009. View Article : Google Scholar : PubMed/NCBI
|
